Promising results in world-first trials for aggressive brain cancer treatment Posted on May 8, 2014February 25, 2018 by Carly du Toit A major breakthrough in the treatment of aggressive brain cancer called Glioblastoma Multiforme (GBM), using immunology has been made by scientists at the QIMR Berghofer Medical Research Institute. Glioblastoma Multiforme (GBM) is the most common malignant brain cancer, diagnosed in about 800 Australians every year with, unfortunately very low five year survival rates. The research used immunology to attack the cancer, and found that of the study participants lived much longer than the six-month prognosis normally given to a patient with recurrent GBM. Some patients showed no signs of disease progression at all. Continue reading “Promising results in world-first trials for aggressive brain cancer treatment”